BRIDGEWAY CAPITAL MANAGEMENT, LLC - SQZ BIOTECHNOLOGIES CO ownership

SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 31 filers reported holding SQZ BIOTECHNOLOGIES CO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of SQZ BIOTECHNOLOGIES CO
ValueSharesWeighting
Q2 2023$17,766
-51.8%
65,8000.0%0.00%
-100.0%
Q1 2023$36,848
-24.3%
65,8000.0%0.00%0.0%
Q4 2022$48,692
-67.5%
65,8000.0%0.00%
-75.0%
Q3 2022$150,000
+15.4%
65,800
+61.3%
0.00%
+33.3%
Q2 2022$130,000
-5.1%
40,800
+43.7%
0.00%0.0%
Q1 2022$137,00028,4000.00%
Other shareholders
SQZ BIOTECHNOLOGIES CO shareholders Q2 2023
NameSharesValueWeighting ↓
NanoDimension, Inc. 1,445,221$6,952,00015.25%
683 Capital Management, LLC 2,098,815$10,096,0000.54%
Artal Group S.A. 1,606,309$7,726,0000.32%
Sandy Cove Advisors, LLC 51,707$249,0000.21%
MAVERICK CAPITAL LTD 1,056,786$5,083,0000.09%
ACT CAPITAL MANAGEMENT, LLC 16,000$77,0000.08%
AMERICAN INTERNATIONAL GROUP, INC. 2,528,477$12,162,0000.07%
Temasek Holdings (Private) Ltd 2,758,169$13,266,7930.06%
Alphabet Inc. 103,929$500,0000.02%
Baldrige Asset Management LLC 5,000$24,0000.01%
View complete list of SQZ BIOTECHNOLOGIES CO shareholders